EVA Therapeutics, Inc.
EVA Therapeutics, Inc. is a startup bio-venture corporation with the vision to implement Dr. Takanori Takebe’s scientific approach to unlock new potential of existing organs in the body to supplement other lost organ functions. The EVA technology is the foundation of our company and its lead project is the intra-rectal delivery of a liquid form of O2 (oxygen) with perfluorocarbon. EVA Therapeutics, Inc is a certified spin-out venture from Tokyo Medical and Dental University. Delivering First-In-Class Organ Repurposing Therapy.